Janssen sues Aurobindo over ANDA


Janssen sues Aurobindo over ANDA

studiocasper-1 / iStockphoto.com

Janssen, a subsidiary of Johnson & Johnson, has sued generics company Aurobindo over the filing of an Abbreviated New Drug Application (ANDA).

Janssen, Aurobindo, Abbreviated New Drug Application, US District Court for the District of New Jersey, Food and Drug Administration, generics

More on this story

Janssen drops biosimilar suit against Samsung